HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis
- 1 August 2006
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 368 (9534), 451-458
- https://doi.org/10.1016/s0140-6736(06)69152-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Prevalence of complete resistance to at least two classes of antiretroviral drugs in treated HIV-1-infected patients: A French nationwide studyJournal of Medical Virology, 2005
- Migration and HIV epidemic in GreeceEuropean Journal of Public Health, 2005
- Newly diagnosed HIV infections: review in UK and IrelandBMJ, 2005
- Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDSInternational Journal of Epidemiology, 2004
- Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapyStatistics in Medicine, 2004
- Epidemiological changes in AIDS and HIV infection in ItalyScandinavian Journal of Infectious Diseases, 2003
- Migrants from Sub-Saharan Africa in the Swiss HIV Cohort StudyAIDS, 2003
- Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patientsAIDS, 2000
- The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997AIDS, 1999
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998